Literature DB >> 26782016

Proximal myopathy with focal depletion of mitochondria and megaconial congenital muscular dystrophy are allelic conditions caused by mutations in CHKB.

L Brady1, M Giri2, J Provias3, E Hoffman2, M Tarnopolsky4.   

Abstract

We recently evaluated two of the original three patients (siblings) diagnosed with Proximal Myopathy with Focal Depletion of Mitochondria. The condition was named for the distinctive pattern of enlarged mitochondria around the periphery of muscle fibres with a complete absence in the middle. These siblings, aged 37 and 40, are cognitively normal with mild non-progressive muscle weakness and a susceptibility to rhabdomyolysis. Both were shown to be compound heterozygotes for novel mutations (c.263C>T + c.950T>A) in CHKB, the gene currently associated with Megaconial Congenital Muscular Dystrophy. Individuals with this condition have early-onset muscle weakness and profound intellectual disability but share the same unique pattern on muscle biopsy as was noted in Proximal Myopathy with Focal Depletion of Mitochondria; focal depletion of mitochondria was surrounded by abnormally large "megaconial" mitochondria. Thus the phenotypic spectrum of CHKB mutations ranges from a congenital muscular dystrophy with intellectual disability to a later-onset non-progressive muscular weakness with normal cognition.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHKB; Megaconial muscular dystrophy; Mitochondrial depletion; Myalgia; Oligomitochondria; Rhabdomyolysis

Mesh:

Substances:

Year:  2015        PMID: 26782016     DOI: 10.1016/j.nmd.2015.11.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.

Authors:  Ambreen A Sayed-Zahid; Roger B Sher; Stacey J Sukoff Rizzo; Laura C Anderson; Kathryn E Patenaude; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

2.  Late-onset megaconial myopathy in mice lacking group I Paks.

Authors:  Giselle A Joseph; Margaret Hung; Aviva J Goel; Mingi Hong; Marysia-Kolbe Rieder; Noam D Beckmann; Madhavika N Serasinghe; Jerry E Chipuk; Parvathi M Devarakonda; David J Goldhamer; Paulina Aldana-Hernandez; Jonathan Curtis; René L Jacobs; Robert S Krauss
Journal:  Skelet Muscle       Date:  2019-02-21       Impact factor: 4.912

3.  Reduced mitochondrial fission and impaired energy metabolism in human primary skeletal muscle cells of Megaconial Congenital Muscular Dystrophy.

Authors:  Evrim Aksu-Menges; Cemil Can Eylem; Emirhan Nemutlu; Merve Gizer; Petek Korkusuz; Haluk Topaloglu; Beril Talim; Burcu Balci-Hayta
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

Review 4.  Megaconial congenital muscular dystrophy due to novel CHKB variants: a case report and literature review.

Authors:  Francesca Magri; Sara Antognozzi; Michela Ripolone; Simona Zanotti; Laura Napoli; Patrizia Ciscato; Daniele Velardo; Giulietta Scuvera; Valeria Nicotra; Antonella Giacobbe; Donatella Milani; Francesco Fortunato; Manuela Garbellini; Monica Sciacco; Stefania Corti; Giacomo Pietro Comi; Dario Ronchi
Journal:  Skelet Muscle       Date:  2022-09-29       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.